Your browser doesn't support javascript.
loading
Enhanced clinical phenotyping by mechanistic bioprofiling in heart failure with preserved ejection fraction: insights from the MEDIA-DHF study (The Metabolic Road to Diastolic Heart Failure).
Stienen, Susan; Ferreira, João Pedro; Kobayashi, Masatake; Preud'homme, Gregoire; Dobre, Daniela; Machu, Jean-Loup; Duarte, Kevin; Bresso, Emmanuel; Devignes, Marie-Dominique; López, Natalia; Girerd, Nicolas; Aakhus, Svend; Ambrosio, Giuseppe; Brunner-La Rocca, Hans-Peter; Fontes-Carvalho, Ricardo; Fraser, Alan G; van Heerebeek, Loek; Heymans, Stephane; de Keulenaer, Gilles; Marino, Paolo; McDonald, Kenneth; Mebazaa, Alexandre; Papp, Zoltàn; Raddino, Riccardo; Tschöpe, Carsten; Paulus, Walter J; Zannad, Faiez; Rossignol, Patrick.
Afiliação
  • Stienen S; CHRU de Nancy, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), INSERM U1116, Centre d'Investigation Clinique et Plurithématique 1433, INSERM, Université de Lorraine, Nancy, France.
  • Ferreira JP; CHRU de Nancy, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), INSERM U1116, Centre d'Investigation Clinique et Plurithématique 1433, INSERM, Université de Lorraine, Nancy, France.
  • Kobayashi M; Department of Physiology and Cardiothoracic Surgery, Cardiovascular Research and Development Unit, Faculty of Medicine, University of Porto, Porto, Portugal.
  • Preud'homme G; CHRU de Nancy, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), INSERM U1116, Centre d'Investigation Clinique et Plurithématique 1433, INSERM, Université de Lorraine, Nancy, France.
  • Dobre D; CHRU de Nancy, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), INSERM U1116, Centre d'Investigation Clinique et Plurithématique 1433, INSERM, Université de Lorraine, Nancy, France.
  • Machu JL; CHRU de Nancy, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), INSERM U1116, Centre d'Investigation Clinique et Plurithématique 1433, INSERM, Université de Lorraine, Nancy, France.
  • Duarte K; Clinical research and Investigation Unit, Psychotherapeutic Center of Nancy, Laxou, France.
  • Bresso E; CHRU de Nancy, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), INSERM U1116, Centre d'Investigation Clinique et Plurithématique 1433, INSERM, Université de Lorraine, Nancy, France.
  • Devignes MD; CHRU de Nancy, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), INSERM U1116, Centre d'Investigation Clinique et Plurithématique 1433, INSERM, Université de Lorraine, Nancy, France.
  • López N; Equipe CAPSID, LORIA (CNRS, Inria NGE, Université de Lorraine), Vandoeuvre-lès-Nancy, France.
  • Girerd N; Equipe CAPSID, LORIA (CNRS, Inria NGE, Université de Lorraine), Vandoeuvre-lès-Nancy, France.
  • Aakhus S; Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad Pública de Navarra (UPNA), IdiSNA, Pamplona, Spain.
  • Ambrosio G; CHRU de Nancy, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), INSERM U1116, Centre d'Investigation Clinique et Plurithématique 1433, INSERM, Université de Lorraine, Nancy, France.
  • Brunner-La Rocca HP; Department of Cardiology and Institute for Surgical Research, Oslo University Hospital, Oslo, Norway.
  • Fontes-Carvalho R; ISB, Norwegian University of Science and Technology, Trondheim, Norway.
  • Fraser AG; Division of Cardiology, University of Perugia School of Medicine, Perugia, Italy.
  • van Heerebeek L; Department of Cardiology, Maastricht University Medical Center, Maastricht, the Netherlands.
  • Heymans S; Department of Surgery and Physiology, Cardiovascular Research Unit (UnIC), Faculty of Medicine, University of Porto, Porto, Portugal.
  • de Keulenaer G; Wales Heart Research Institute, Cardiff University, Cardiff, UK.
  • Marino P; Department of Cardiology, Onze Lieve Vrouwe Gasthuis, Amsterdam, the Netherlands.
  • McDonald K; Department of Cardiology, CARIM School for Cardiovascular Diseases Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, the Netherlands.
  • Mebazaa A; Department of Cardiovascular Sciences, Centre for Molecular and Vascular Biology, Leuven, Belgium.
  • Papp Z; William Harvey Research Institute, Barts Heart Centre, Queen Mary University of London, London, UK.
  • Raddino R; Laboratory of Physiopharmacology, Antwerp University, and ZNA Hartcentrum, Antwerp, Belgium.
  • Tschöpe C; Clinical Cardiology, Università del Piemonte Orientale, Department of Translational Medicine, Azienda Ospedaliero Universitaria "Maggiore della Carità", Novara, Italy.
  • Paulus WJ; School of Medicine and Medical Sciences, St Michael's Hospital Dun Laoghaire Co. Dublin, Dublin, Ireland.
  • Zannad F; Department of Anaesthesiology and Critical Care Medicine, Saint Louis and Lariboisière University Hospitals and INSERM UMR-S 942, Paris, France.
  • Rossignol P; Division of Clinical Physiology, Department of Cardiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Biomarkers ; 25(2): 201-211, 2020 Mar.
Article em En | MEDLINE | ID: mdl-32063068
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fenótipo / Insuficiência Cardíaca Tipo de estudo: Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fenótipo / Insuficiência Cardíaca Tipo de estudo: Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article